Mark Twyman Email & Phone Number

Glenside, PA, US

Plymouth Meeting PA And San Diego CA

Plymouth Meeting, Pennsylvania

Boston, Massachusetts

Pharma and Biotechnology Commercial Consulting.

Gaithersburg Maryland

• After one year consulting engagement recruited by CEO and SVP Commercial in December of 2015 to develop and execute marketing plan in anticipation of successful phase 3 outcome and 2018 commercial launch of RSV vaccine.
• Developed launch plan for RSV Vaccine for Older Adults, a potential $2-$4 billion a year US market opportunity
• Developed and executed pre-launch market research plan for both the Older Adult and Infant RSV vaccines
• Led effort to develop Strategic Scientific Communications platform and all positioning and messaging related to RSV burden of disease, unmet medical need, vaccine technology platform and vaccine safety and efficacy for.
• Working with Brand Institute, managed global vaccine naming initiative for older adult and infant vaccines
• Created and launched multi-channel older adult HCP disease awareness campaign anchored by DiscoverRSV.com and industry leading conference presence.

Orlando, Florida

• Beating the "bigs" in the Femtosecond Cataract Laser space! Recruited by CEO to establish marketing center of excellence for small but innovative ophthalmology company ahead of anticipated M&A activity. Significant.
• Establish best practices for strategy development, positioning and messaging for the lead product
• Successfully branded the lead product and established high levels of global market recognition for the brand and the product

Lexington, MA

• Chief Commercial Officer Recruited by CEO and BOD of start-up company to commercialize EndoBarrier ex-US, a CE marked (2011) innovative device technology in the obesity and type 2 diabetes market. Full accountability.
• Recruited key talent, VP Marketing, Director EU Reimbursement, Commercial Manager Australia, Site Trainers
• Achieved major reimbursement milestones in Germany, Netherlands, France, Israel and Australia
• Established over 70 hospital based EndoBarrier Therapy Centers in both reimbursed and self-pay markets in Europe, LATAM, Australia, Middle East and Israel
• Led effort to identify and partner with Brazil based manufacturer to accelerate time to market in Brazil
• Coordinated initial EU and LATAM Endocrinologist, Diabetologist, Bariatric Surgery and Gastroenterology Advisory Boards and Users Meetings

• SVP and GM Global Commercial and P&L responsibility for Genzyme's $400M visco-supplement franchise (Synvisc, Synvisc-One, Jonexa). Recruited by President of Biosurgery Division to successfully manage the global launch.
• Grew Synvisc Franchise revenue in excess of 20% per year, grew franchise market share and improved product gross margins
• Through innovative marketing, including strategic use of web based promotion, DTC and earned media established Synvisc-One as premium brand in the market creating separation from other brands and commoditization of the.
• Recruited Hank Aaron for extremely successful PR campaign for Synvisc-One
• Played a key role with Business Development to identify a Japanese partner to launch Synvisc-One. Once selected, worked closely with Teijin Pharma to coordinate launch of the Synvisc franchise in Japan. Launch planning.
• Led effort to partner with Abiogen Pharma Italy to launch previously “shelved” alternative visco-supplement formulation, Jonexa, to compete in the highly price sensitive Italian visco-supplement market.

• SVP and GM Recruited by CEO to turn-around Flumist seasonal flu vaccine, develop a Pandemic Flu strategy and to support overall corporate decision making. Directly managed a team of 10 Marketing and Strategic.
• Recruited new marketing talent to support mission critical turn-around objective for Flumist; broke through critical $100 million sales target
• Developed and launched completely revamped marketing campaign for Flumist, including first ever DTC campaign which led to significant growth in market acceptance of first in class nasally administered, live attenuated.
• Led effort with manufacturing to develop refrigerator, versus freezer, stable formulation of Flumist which had previously been a barrier to adoption with pediatricians
• Led effort with clinical development to improve labeling and increase patient access opportunities for Flumist
• Worked internally and with global health authorities to design a pandemic flu product development and access strategy for both pre and post-pandemic vaccine

• VP Global Pediatric Vaccine Marketing last position held at Merck. Marketing responsibility for Merck's $1B, 6 product, pediatric vaccine franchise. Launched multiple new vaccines. Prior to that held a number of.
• Pharmaceutical Drug Representative
• Market Research Analyst - Cardiovascular
• Promotion Manager - Cardiovascular
• Product Manager – Hepatitis B Vaccines
• Director Sales and Marketing Operations Vaccines

Pittsbugh, PA

Public Finance Group - Healthcare and Higher Education